Composition for neurological or autoimmune diseases
AssigneeNational Institutes of Health (Nih), U.S. Dept. of Health and Human Services (Dhhs), U.S. Government
InventorDaniel L. Kaufman
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition effective for a neurological disease or an autoimmune disease and methods of making and using the same.
Claims22
A composition, which is a vaccine composition or a pharmaceutical composition, comprising an effective amount of Bacillus Calmette-Guerin (BCG) and an optional second agent, wherein the composition is effective for inhibiting the progress of a neurological disease or causing a neurological disease to progress at a slower rate.
The composition of claim 17, wherein the compound binds to TLR-4 or TLR-2.
Dependencies are inferred from the claim text.